BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 12636464)

  • 1. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral associations between prostate and colon cancer screening.
    Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
    J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
    Seeff LC; Manninen DL; Dong FB; Chattopadhyay SK; Nadel MR; Tangka FK; Molinari NA
    Gastroenterology; 2004 Dec; 127(6):1661-9. PubMed ID: 15578502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.
    Ross KS; Carter HB; Pearson JD; Guess HA
    JAMA; 2000 Sep; 284(11):1399-405. PubMed ID: 10989402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
    Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
    Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer screening in Queensland men.
    Carrière P; Baade P; Newman B; Aitken J; Janda M
    Med J Aust; 2007 Apr; 186(8):404-7. PubMed ID: 17437394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit.
    Hall HI; Van Den Eeden SK; Tolsma DD; Rardin K; Thompson T; Hughes Sinclair A; Madlon-Kay DJ; Nadel M
    Prev Med; 2004 Jul; 39(1):27-35. PubMed ID: 15207983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.
    Hayes JH; Barry MJ
    JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
    Chun FK; Suardi N; Perrotte P; Lebeau T; Guay JP; Benayoun S; Ramirez A; Bénard F; McCormack M; Valiquette L; Karakiewicz P
    Can J Urol; 2007 Dec; 14(6):3727-33. PubMed ID: 18163923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening among men and women in the United States.
    Peterson NB; Murff HJ; Ness RM; Dittus RS
    J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index and cancer screening in older American Indian and Alaska Native men.
    Muus KJ; Baker-Demaray T; McDonald LR; Ludtke RL; Allery AJ; Bogart TA; Goldberg J; Ramsey SD; Buchwald DS
    J Rural Health; 2009; 25(1):104-8. PubMed ID: 19166569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Cancer Screening Among Hopi Men.
    Batai K; Sanderson PR; Hsu CH; Joshweseoma L; Russell D; Joshweseoma L; Ojeda J; Burhansstipanov L; Brown SR; Ami D; Saboda K; Harris RB
    J Cancer Educ; 2022 Aug; 37(4):915-923. PubMed ID: 33083892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Drazer MW; Huo D; Eggener SE
    J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.
    Li J; Zhao G; Pollack LA; Smith JL; Joseph DA
    Prev Chronic Dis; 2010 Jul; 7(4):A84. PubMed ID: 20550842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of colorectal cancer screening adherence among men who have been screened for prostate cancer.
    Wong YN; Coups EJ
    J Cancer Educ; 2011 Jun; 26(2):301-7. PubMed ID: 21360029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
    de Koning HJ; Auvinen A; Berenguer Sanchez A; Calais da Silva F; Ciatto S; Denis L; Gohagan JK; Hakama M; Hugosson J; Kranse R; Nelen V; Prorok PC; Schröder FH; ;
    Int J Cancer; 2002 Jan; 97(2):237-44. PubMed ID: 11774270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.